Figo stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973‐87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

Seminars in Surgical Oncology

Volumn 10, Issue 1, 1994, Pages 31-46

  Kosary, Carol L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

all sites; cancer; Cox proportional hazards model; survival; survival rate

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CERVIX NEOPLASMS; DATABASES, FACTUAL; ENDOMETRIAL NEOPLASMS; FEMALE; FORECASTING; GENITAL NEOPLASMS, FEMALE; HUMAN; LYMPHATIC METASTASIS; MIDDLE AGE; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASM STAGING; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 0028084765     PISSN: 87560437     EISSN: 10982388     Source Type: Journal    
DOI: 10.1002/ssu.2980100107     Document Type: Article

References (96)

1. Survival of patients with ovarian cancer: Apart from stage and grade, tumor progester‐one receptor content is a prognostic indicator
2. Invasive Vaginal Carcinoma: analysis of early‐stage disease
3. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factor sin survival (a gynecologic oncology group study)
4. Squamous cell carcinoma of the vulva: prognostic factors influencing survival
5. Radiation management of primary carcinoma of the vagina: clinical and Histopathological variables associated with survival
6. Prognostic factors in ovarian cancer
7. Screening of gynecologic cancer: vulvar, vaginal, endometrial, and ovarian neoplasm
8. The new international federation of gynecology and obstetrics surgical staging and survival rates in early endometrial carcinoma
9. Increased incidence of adenocarcinoma of uterine cervix
10. Treatment of primary adenocarcinoma of the cervix
11. Adenocarcinoma of the uterine cervix
12. Epidemiological differences between adeno‐carcinoma and squamous cell carcinoma of the uterine cervix
13. Cure rate estimation and long term prognosis of uterine cervix carcinoma
14. Adenocarcinoma of the uterine cervix. A study of 73 cases
15. Gland cell carcinoma (adenocarcinoma) of the cervix
16. The prognosis and treatment of stage I adenocarcinoma of the cervix
17. Analysis of prognostic feature in adenocarcinoma of the cervix
18. Results of radio‐therapeutic management of carcinoma of the cervix with emphasis on the influence of histologic classification
19. Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariate analysis of the effect of age, stage, histology, and blood counts on survival
20. Prognosis of the adenocarcinoma of the cervix uteri: a comparative study
21. Adenocarcinoma of the uterine cervix: prognosis and patters of failure in 367 cases
22. Adenocarcinoma of the uterine cervix
23. Adenocarcinoma of the uterine cervix
24. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix
25. A comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population‐based epidemiologic study
26. Premalignant and malignant disorders of the uterine corpus
27. Serous papillary carcinoma of the endo‐metrium. A clinicopathologic study of 11 cases
28. Endometrial papillary adenocarcinoma: two clinicopathologic types
29. Papillary serous adeno‐carcinoma of the endometrium
30. Uterine papillary serous carcinoma
31. The prognosis on early endometrial carcinoma: the importance of uterine papillary serous carcinoma, age, FIGO grade and nuclear grade
32. Virulence of papillary endometrial cancer
33. Serous papillary carcinoma of the endometrium. A histologic study of 22 cases
34. Papillary carcinomas of the endometrium
35. Uterine papillary serous carcinoma: a study of 108 cases with emphasis on the prognostic significance of associated endometroid carcinoma, absence of invasion, and concomitant ovarian cancer
36. Clear cell carcinoma of the endometrium: an analysis of 21 cases
37. Mixed adenosquamous carcinoma of the endometrium
38. Adenosquamous and mixed adenosquamous carcinoma of the endometrium. A clinicio‐pathological study
39. Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis?
40. Treatment of patients with sarcoma of the uterus
41. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma
42. Clinical and histological studies of ovarian carcinoma: long term follow up of 990 cases
43. The pathological assessment of ovarian neoplasm. I. Introduction to the common epithelial tumors and analysis off benign epithelial tumors
44. The pathological assessment of ovarian neoplasm. II. The proliferating epithelial tumors
45. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma
46. Endometroid carcinoma of the ovary. A clinicopathological study of 75 cases
47. Long term follow‐up and prognostic factors in ovarian carcinoma. The Radiumhemmet series 1458 to 1973
48. Ovarian carcinoma: a multivariate analysis of prognostic factors
49. Prognostic factors in survival in stage I epithelial ovarian carcinoma
50. Gynecologic Tumors
51. Premalignant and malignant disorders of the vulva and vagina
52. Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer
53. Prognostic importance of histologic grading in ovarian cancer
54. Epithelial carcinoma of the ovary: prognostic importance of histologic grade
55. Histological correlations of virulence in ovarian adenocarcinoma. 1. Effects of differentiation
56. Prognostic factors for overall survival in patients with advanced ovarian carcinoma
57. Surgical staging in endometrial cancer: clinical‐pathologic findings of a prospective study
58. 5‐year survival rate in endometroid carcinoma stage I‐II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion
59. Prognostic factors associated with radical hysterectomy failures
60. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy in stage Ib and IIa carcinoma of the cervix
61. Prognostic factors in stage Ib squamous cervical cancer patients with low risk for recurrence
62. Prognostic variables in the treatment of squamous cell carcinoma of the vulva
63. Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I
64. Prognostic factors in endometrial cancer
65. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer
66. Lymphvascular space involvement: a prognostic indicator in endometrial adeno‐carcinoma
67. Proposal of a modified (FIGO 1985) classification of stages I and II cancer of the uterine cervix
68. The influence of some prognostic factors on the outcome of patients with squamous cell carcinoma of the vulva
69. Positive peritoneal cytology is an adverse factor in endometrial cancer only if there is other evidence of extrauterine disease
70. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy
71. Carcinoma of the vulva: Critical analysis of survival and treatment recurrences
72. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage II and IVa FIGO
73. Ovarian cancer: age contrasts in incidence, histology, stage at diagnosis, and mortality
74. Ovarian cancer: survival and treatment differences by age
75. Age and prognosis in stage Ib squamous cell carcinoma of the uterine cervix
76. Cervical carcinoma: prognosis in younger patients
77. Young age as a prognostic factor in cervical cancer: analysis of population based data from 10022 cases
78. Cervical cancer: women aged 35 and younger compared to women aged 36 and older
79. Carcinoma of the cervix; the effect of age on survival
80. The influence of patients' age and tumor grade on the prognosis of carcinoma of the cervix
81. Invasive cervical cancer in young women
82. Carcinoma of the cervix in young females (35 years and younger)
83. Invasive squamous cell carcinoma of the cervix in women less than 35 years old: recurrent verses nonrecurrent disease
84. Age as a prognostic factor in patients with squamous cell carcinoma of the uterine cervix
85. Prognostic significance of age in stage I carcinoma of the cervix
86. Invasive carcinoma of the cervix in young women
87. Cervical carcinoma in women aged 34 and younger
88. Prognostic and treatment factors affecting pelvic control of stage Ib and IIa‐b carcinoma of the intact uterine cervix treated with radiation therapy alone
89. Cancer patient survival experience. Trends on survival 1960‐63 to 1970‐73
90. A collaborative study of differences in the survival rates of black patients and white patients with cancer
91. The relative survival rate: a statistical methodology
92. Regression models and life tables